Subcommittees are responsible for two or more related documents in a topic area. They write draft documents, evaluate and respond to comments on content throughout the document development process, conduct scheduled document reviews, and may be responsible for continual revision of certain documents.
CLSI has established subcommittees in the following areas:
The AST Subcommittee provides useful information to laboratories, enabling them to advise clinicians in the selection of appropriate antimicrobial therapy.
The Antifungal Subcommittee collaborates to develop standards and guidelines that promote accurate antifungal susceptibility testing and appropriate reporting.
The VAST Subcommittee collaborates to develop standards and guidelines that promote accurate antimicrobial susceptibility testing and appropriate reporting.
Meeting Presentation Minutes
M100 Resources
Other Tools Used for Decisions
AST News Updates
Webinars
Other
This document includes updated tables for the Clinical and Laboratory Standards Institute antimicrobial susceptibility testing standards M02, M07, and M11.
Providing the scientific reasons behind breakpoint decisions.
This guideline discusses the necessary and recommended data for selecting appropriate breakpoints and quality control ranges for antimicrobial agents.
This document includes updated tables for the Clinical and Laboratory Standards Institute veterinary antimicrobial susceptibility testing standard VET01.
Hear directly from our volunteers about their experience volunteering on CLSI AST Subcommittees.
January-February 2021
Virtual
June 2021
Virtual
August-October 2020
Virtual
January 23–26, 2020
Tempe, Arizona, USA
AST and Antifungal Staff Liaison | Marcy L. Hackenbrack, MCM, M(ASCP)
VAST Staff Liaison | Lori T. Moon, MS, MT(ASCP)
Thursday, January 21, 2021 | 1:00–2:00 PM Eastern (US) Time
This document provides epidemiological cutoff values developed according to the criteria in the Clinical and Laboratory Standards Institute (CLSI) guideline M57 and generated according to the reference broth dilution methods described in the CLSI standards M27 and M38.
This document provides updated minimal inhibitory concentration, zone diameter, and quality control tables for the Clinical and Laboratory Standards Institute antifungal susceptibility testing documents M27 and M44.
This document provides minimal inhibitory concentration breakpoints and quality control tables for the Clinical and Laboratory Standards Institute antifungal susceptibility testing documents M38 and M51.